Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial.
about
Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Meglumine antimoniate intrales ...... abel, phase II clinical trial.
@en
Meglumine antimoniate intrales ...... abel, phase II clinical trial.
@nl
type
label
Meglumine antimoniate intrales ...... abel, phase II clinical trial.
@en
Meglumine antimoniate intrales ...... abel, phase II clinical trial.
@nl
prefLabel
Meglumine antimoniate intrales ...... abel, phase II clinical trial.
@en
Meglumine antimoniate intrales ...... abel, phase II clinical trial.
@nl
P2093
P2860
P356
P1476
Meglumine antimoniate intrales ...... label, phase II clinical trial
@en
P2093
Ana Rabello
Dario Brock Ramalho
Gláucia Cota
Hugo Silva Assis Moreira
Lara Saraiva
Maria Camilo Ribeiro de Senna
Mariana Junqueira Pedras
Rosiana Estéfane da Silva
P2860
P304
P356
10.1590/0074-02760180200
P577
2018-06-21T00:00:00Z